Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9071 |
High Similarity |
NPD6190 |
Approved |
0.8138 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7834 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7724 |
Intermediate Similarity |
NPD943 |
Approved |
0.7711 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7655 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7584 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7574 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.74 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7355 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7351 |
Intermediate Similarity |
NPD9570 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7321 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7312 |
Intermediate Similarity |
NPD37 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7286 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD7054 |
Approved |
0.726 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7259 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7259 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7248 |
Intermediate Similarity |
NPD826 |
Approved |
0.7248 |
Intermediate Similarity |
NPD825 |
Approved |
0.7241 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7225 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7228 |
Approved |
0.717 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7161 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7132 |
Intermediate Similarity |
NPD2067 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7123 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7122 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7108 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7059 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7051 |
Intermediate Similarity |
NPD3400 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7021 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7019 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7013 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7013 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7007 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6988 |
Remote Similarity |
NPD919 |
Approved |
0.6987 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD555 |
Phase 2 |
0.6968 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD1535 |
Discovery |
0.6959 |
Remote Similarity |
NPD257 |
Approved |
0.6959 |
Remote Similarity |
NPD258 |
Approved |
0.6954 |
Remote Similarity |
NPD8312 |
Approved |
0.6954 |
Remote Similarity |
NPD6663 |
Approved |
0.6954 |
Remote Similarity |
NPD8313 |
Approved |
0.695 |
Remote Similarity |
NPD4198 |
Discontinued |
0.6946 |
Remote Similarity |
NPD5494 |
Approved |
0.6943 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD3750 |
Approved |
0.6933 |
Remote Similarity |
NPD7411 |
Suspended |
0.6923 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6923 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD1608 |
Approved |
0.6918 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6913 |
Remote Similarity |
NPD5736 |
Approved |
0.6908 |
Remote Similarity |
NPD1240 |
Approved |
0.6906 |
Remote Similarity |
NPD228 |
Approved |
0.6905 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD1501 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD6032 |
Approved |
0.6892 |
Remote Similarity |
NPD2797 |
Approved |
0.6875 |
Remote Similarity |
NPD2534 |
Approved |
0.6875 |
Remote Similarity |
NPD2532 |
Approved |
0.6875 |
Remote Similarity |
NPD2533 |
Approved |
0.6867 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6865 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6863 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD1933 |
Approved |
0.6861 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD5762 |
Approved |
0.6859 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6859 |
Remote Similarity |
NPD5763 |
Approved |
0.6849 |
Remote Similarity |
NPD1201 |
Approved |
0.6848 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6846 |
Remote Similarity |
NPD5647 |
Approved |
0.6842 |
Remote Similarity |
NPD259 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6828 |
Remote Similarity |
NPD8319 |
Approved |
0.6828 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6824 |
Remote Similarity |
NPD5242 |
Approved |
0.6824 |
Remote Similarity |
NPD1283 |
Approved |
0.6818 |
Remote Similarity |
NPD1607 |
Approved |
0.6818 |
Remote Similarity |
NPD6653 |
Approved |
0.6809 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6805 |
Remote Similarity |
NPD1247 |
Approved |
0.68 |
Remote Similarity |
NPD9569 |
Approved |
0.6797 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6796 |
Remote Similarity |
NPD6535 |
Approved |
0.6796 |
Remote Similarity |
NPD6534 |
Approved |
0.6795 |
Remote Similarity |
NPD2796 |
Approved |
0.6783 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD3847 |
Discontinued |
0.6776 |
Remote Similarity |
NPD3268 |
Approved |
0.677 |
Remote Similarity |
NPD3146 |
Approved |
0.677 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.677 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.677 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6752 |
Remote Similarity |
NPD2344 |
Approved |
0.6752 |
Remote Similarity |
NPD2353 |
Approved |
0.6752 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6747 |
Remote Similarity |
NPD7972 |
Discontinued |
0.6743 |
Remote Similarity |
NPD7039 |
Approved |
0.6743 |
Remote Similarity |
NPD7038 |
Approved |
0.6743 |
Remote Similarity |
NPD7240 |
Approved |
0.6739
|
Remote Similarity |
NPD1358 |
Approved |